An article published by the Heart Rhythm Society’s journal Heart Rhythm O2 concludes that Vektor’s Computational ECG Mapping System (vMap™) and protocol-based respiratory gating may help facilitate ...

All patients in the study group (n=27) and controls (n=54) underwent standard-of-care pulmonary vein isolation (PVI). Following PVI, the study group (n=27) had ablation of 1.6 ± 0.7 additional AF ...

Milestone Highlights Rapid Hospital Adoption and Clinical Demand for Arrhythmia Insights that Improve Outcomes and Reduce Procedure Time vMap, developed with AI and designed to localize both focal and ...

Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced the publication of a peer-reviewed study in EP Europace evaluating vMap-guided activation mapping and ...

Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced that Ascension St. Vincent's has enrolled the first patient in the VITAL-EP study. The study is ...

Vektor Medical Receives FDA 510(k) Clearance Adding Atrial Flutter Mapping, Enhanced Connectivity and New Integration Capabilities to Next-Generation vMap Clearance Expands vMap’s Non-Invasive Mapping ...

The knowledge that recovering Covid-19 patients face an increased risk of cardiac arrhythmia(Opens in a new window) complications, is one factor contributing to the ...

Vektor Medical, the developer of the vMap AI-based system for mapping arrhythmias using a standard 12-lead ECG, has released a series of software enhancements to the non-invasive solution. The ...